Skip to content

CETIC-I (CEra Traction Improves Cervical Kyphosis -I)

A Prospective, Randomized, Single-blinded, Sham Device Controlled, Parallel Treatment Grouped, Multi-center, Exploratory Clinical Trial to Evaluate Improvement of Cervical Lordosis and Safety of CGM MB-1701 in Subjects With Cervical Kyphosis and Posterior Neck Pain.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05469295
Enrollment
30
Registered
2022-07-21
Start date
2023-05-09
Completion date
2024-07-26
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Kyphosis, Cervical Lordosis, Kyphosis

Brief summary

The study is a Prospective, Randomized, Single-blinded, Sham device controlled, Parallel Treatment Grouped, Multi-center, Exploratory Clinical Trial to Evaluate Improvement of Cervical Lordosis and Safety of CGM MB-1701 (Spinal warm massage device, Ceragem Master V6) in Subjects with Cervical Kyphosis and Posterior Neck Pain.

Detailed description

The Cervical Kyphosis are also commonly referred to as "turtle neck syndrome." It refers to the deformation of the neck bone into an inverted C-shape due to abnormalities or degenerative changes, and it is named to mean that the neck is bent like a turtle. This device, Ceragem Master V6 (CGM MB-1701), has been certified as a combination of a personal warmer that can be used to relieve muscle pain by applying constant heat to the human body and a medical vibrator of a device that applies physical energy (vibration, shock, pressure, etc.). Also, the device got approval for use with intermittent pneumatic compression and electrically-powered orthopedics traction. The primary purpose of this clinical trial is to confirm the temporary cervical lordosis angle improvement (height) in subjects with cervical kyphosis through the combined function of the test device.

Interventions

DEVICECGM MB-1701 device treatment

This is a pre-approved motorized traction device.

DEVICECGM MB-1701 Sham device treatment

It is manufactured in the same way as the test device and the operation pattern. However, the actual effect of the massage is minimized.

Sponsors

Ceragem Clinical Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Adult male and female subjects who have voluntarily decided to participate and agreed in writing after being briefed on the characteristics of this clinical trial and medical device 2. Subjects with cervical kyphosis angle between cervical lordosis 20 degrees and cervical kyphosis 5 degrees. 3. BMI betweeen 18.5 and 30 4. Chronic neck pain NRS 4 or higher lasting more than 3 months

Exclusion criteria

1. Secondary spondylosis 2. A tumor of the spine 3. Inflammatory spondylitis 4. Myelopathy 5. Multiple adjacent radiculopathies and others

Design outcomes

Primary

MeasureTime frameDescription
Mean change of cervical lordosisup to 16 weeksMean change of cervical lordosis using posterior tangent method of Harrison measured by cervical lateral radiography at EOT (End of Trial) compared to baseline.

Secondary

MeasureTime frameDescription
Change of cervical lordosis at 2nd interim analysisup to 16 weeksChange of the cervical lordosis (posterior tangent method of Harrison) measured by cervical lateral radiography at the 2nd interim visit compared to baseline.
Cervical vestibular angle increase more than 10 degreesup to 16 weeksThe fraction of subjects whose cervical vestibular angle measured by the posterior tangent method of Harrison at each time of evaluation increased by more than 10 degrees compared to the baseline
Anteroposterior (T1) slope average changeup to 16 weeksAverage change in cervical anteroposterior (T1) slope measured by cervical lateral radiography at each evaluation compare to the baseline

Countries

South Korea

Contacts

PRINCIPAL_INVESTIGATORYong Il Shin, MD

Pusan National University Yangsan Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026